Replies to post #687107 on NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

Bas2020 I think your description is exactly what franchise means. Licensing the platform and Eden’s from trial to commercialization.
The entire industry has changed dramatically because of new precise forecasting tools, dendretic cell as a platform, length of trials,number of participants in trials, personalized therapies and all made commercially feasible via Eden’s.
Franchises are turnkey operations and that’s what we have.

[Truthfan]

“Certainly, we don't know what is meant by "franchise", but it could be as simple as licensing out the technology to others who can produce it for their designated markets, including use in combo therapies.”

Yes, of course, many opportunities present themselves with NWBO’s breakthrough technology but with the current silence, we can only speculate. The point I was attempting to highlight in my post was the “administered in community settings” verbiage wherein brick and mortar location is not always available.

Further, an interesting nugget, EW Healthcare Partners held Cognate BioServices in their portfolio overseen by Evis Hursever, Managing Director, prior to CRL buyout. Presently, Ms. Hursever, chairs the Board of Germfree,

Thank you for adding additional information; we only have each other to depend on as we offer our thoughts and due diligence despite all the neighborhood pests on the board.

Best